immunomodulation

Type: Keyphrase
Name: immunomodulation
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Connecting the Lab and the Clinic in Regenerative Medicine

An interview with the director of the Translational Tissue Engineering Center at Johns Hopkins University School of Medicine can be found at the Methuselah Foundation blog : We named it the Translational Tissue Engineering Center because we're focused ... [Published Fight Aging! - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Curie-Cancer, Inventiva partners in epigenetics for cancer

Curie-Cancer , the body responsible for Institut Curie ’s industry partnership activities, and Inventiva , a French drug discovery company focusing on therapeutic approaches involving transcription factors and epigenetic targets, have launched the Epicure ... [Published Center Watch - Sep 18 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 2 reports

Researchers from University of Wisconsin Detail Findings in Stem Cells (Biomaterial-Mesenchymal Stem Cell Constructs for Immunomodulation in...

Researchers from University of Wisconsin Detail Findings in Stem Cells (Biomaterial-Mesenchymal Stem Cell Constructs for Immunomodulation in Composite Tissue Engineering) (Biomaterial-Mesenchymal Stem Cell Constructs for Immunomodulation in ...) By a ... [Published Wall Street Business Network - Sep 17 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Form: Non-technical summaries granted during 2013: volume 37

The following projects are listed in volume 37 of 2013:cortical networks underlying primate choice (covering prefrontal cortex, neuronal networks, electrophysiology, lesions, non-human primate) physician aided reconstitution of immune system (covering ... [Published HM Treasury - Sep 15 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Merck's Mantra On Focus Precludes An Inversion Strategy

Merck recently scored a major triumph for itself and melanoma patients with the approval of an important new drug, Keytruda (pembrolizumab). Keytruda is an entry in the exciting new area of anti-cancer drugs known as immunomodulators, drugs that help ... [Published Forbes.com - Sep 15 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

France's algae-covered beaches could mean big business

For decades, Brittany has been plagued by green algae piling up on its beaches, causing serious health hazards to animals and humans. Now, the region hopes to cash in on the toxic seaweed by taking advantage of its rare biologically active compounds.“The ... [Published France24 - Sep 15 2014]
First reported Sep 10 2014 - Updated Sep 11 2014 - 1 reports

Scientists discover how to 'switch off' autoimmune diseases

By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- Scientists have made an important breakthrough in the fight against debilitating autoimmune diseases such as multiple sclerosis by revealing how to stop cells attacking healthy body ... [Published HispanicBusiness.com - Sep 10 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

Gene therapy for cancer: present status and future perspective

Advancements in human genomics over the last two decades have shown that cancer is mediated by somatic aberration in the host genome. This discovery has incited enthusiasm among cancer researchers; many now use therapeutic approaches in genetic manipulation ... [Published 7thSpace - Sep 10 2014]
First reported Sep 04 2014 - Updated Sep 05 2014 - 1 reports

Influenza Vaccination of Pregnant Women and Protection of Their Infants

Pregnant women are designated as a priority group for seasonal influenza vaccination by the World Health Organization (WHO) because of their heightened susceptibility to severe influenza from the second trimester to the early postpartum period. Since ... [Published The New England Journal of Medicine: Obstetrics ... - Sep 04 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

US CNS Disorders Drug Pipeline Insight 2014

The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. The numbers of CNS disorders have increased at an alarming rate, while the available therapies were unable to meet the market requirements. ... [Published Individual.com - Aug 28 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

Global Tissue Engineering and Regeneration Market to Reach $56.9 Billion in 2019

BCC Research reveals in its new report, Tissue Engineering and Regeneration: Technologies and Global Markets , the global market for tissue engineering and regeneration is expected to grow to $56.9 billion by 2019, with a five-year compound annual growth ... [Published Medical Design Technology - Aug 18 2014]
First reported Aug 08 2014 - Updated Aug 08 2014 - 1 reports

[Editorial] Skin cancer: prevention is better than cure

Skin cancer is now the most commonly diagnosed cancer in the USA with about 5 million people treated every year. In Germany, the Federal Statistics Bureau reported last week that treatment for skin cancer in hospital has risen more than that for any other ... [Published The Lancet - Aug 08 2014]

Quotes

According to the news reporters, the research concluded: "Better understanding of the interactions between biomaterials and cells could translate to the development of clinically relevant and novel cell-based therapeutics for tissue reconstruction and regenerative medicine."
"##STR00003## wherein: g.sub.2, g.sub.3, g.sub.4, g.sub.5, and g.sub.6 and w.sub.3, w.sub.4, w.sub.5 and w.sub.6 are identical or different and are independently hydrogen, a chlorine atom or a bromine atom, a (C.sub.1-C.sub.3)-alkyl, a (C.sub.1-C.sub.3)-alkoxy, a trifluoromethyl or a nitro group and g.sub.4 is optionally a phenyl group; R sub.4 is hydrogen or a (C.sub.1-C.sub.3)-alkyl;"

More Content

All (62) | News (54) | Reports (0) | Blogs (7) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Blood Transfusions & Infection Risk [Published Physicians Weekly - Sep 19 2014]
Connecting the Lab and the Clinic in Regenerati... [Published Fight Aging! - Sep 18 2014]
Curie-Cancer, Inventiva partners in epigenetics... [Published Center Watch - Sep 18 2014]
Researchers from University of Wisconsin Detail... [Published Wall Street Business Network - Sep 17 2014]
Researchers from University of Wisconsin Detail... [Published HispanicBusiness.com - Sep 17 2014]
NEKTAR THERAPEUTICS : Patent Issued for Oligome... [Published 4 Traders - Sep 17 2014]
Risk Factors for Surgical Site Infection Follow... [Published Journal of Bone and Joint Surgery - Sep 17 2014]
HDL Cholesterol and CVD Mortality in Hemodialys... [Published General Medicine eJournal - Sep 17 2014]
Curie-Cancer And Inventiva Announce A Partnersh... [Published BioSpace - Sep 16 2014]
Form: Non-technical summaries granted during 20... [Published HM Treasury - Sep 15 2014]
Merck's Mantra On Focus Precludes An Inversion ... [Published Forbes.com - Sep 15 2014]
France's algae-covered beaches could mean big b... [Published France24 - Sep 15 2014]
Unique Antibody Responses to Malondialdehyde-Ac... [Published Plosone.org - Sep 11 2014]
Patent Application Titled "Compositions and Met... [Published 4 Traders - Sep 11 2014]
"Mutant Ctla4 Gene Transfected T Cell and Compo... [Published HispanicBusiness.com - Sep 10 2014]
Scientists discover how to 'switch off' autoimm... [Published HispanicBusiness.com - Sep 10 2014]
Genzyme to Feature Multiple Sclerosis Pipeline ... [Published Pharmacy Choice - Sep 10 2014]
Gene therapy for cancer: present status and fut... [Published 7thSpace - Sep 10 2014]
Ludwig Cancer Research and CRI collaborate on V... [Published 4 Traders - Sep 10 2014]
Infection with Host-Range Mutant Adenovirus 5 S... [Published Plosone.org - Sep 09 2014]
Genzyme to Feature Multiple Sclerosis Pipeline ... [Published Wall Street Select - Sep 08 2014]
Flavonoid Apigenin Inhibits Lipopolysaccharide-... [Published Plosone.org - Sep 06 2014]
Reports from Health Institute Describe Recent A... [Published HispanicBusiness.com - Sep 04 2014]
Influenza Vaccination of Pregnant Women and Pro... [Published The New England Journal of Medicine: Obstetrics ... - Sep 04 2014]
20% Disc. US CNS Disorders Drug Pipeline Insigh... [Published Prlog - Sep 02 2014]
Psychobiotics and Their Involvement in Mental H... [Published Sexual Development - Aug 29 2014]
Agonistic Anti-CD40 Enhances the CD8+ T Cell Re... [Published Plosone.org - Aug 28 2014]
Merck Animal Health to Sponsor 10th Internation... [Published The Fish Site - Aug 28 2014]
Drug Delivery in Cancer 2014: Technologies, Mar... [Published Pharmacy Choice - Aug 28 2014]
US CNS Disorders Drug Pipeline Insight 2014 [Published Individual.com - Aug 28 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Connecting the Lab and the Clinic in Regenerati... [Published Fight Aging! - Sep 18 2014]
An interview with the director of the Translational Tissue Engineering Center at Johns Hopkins University School of Medicine can be found at the Methuselah Foundation blog : We named it the Translational Tissue Engineering Center because we're focused ...
Influenza Vaccination of Pregnant Women and Pro... [Published The New England Journal of Medicine: Obstetrics ... - Sep 04 2014]
Pregnant women are designated as a priority group for seasonal influenza vaccination by the World Health Organization (WHO) because of their heightened susceptibility to severe influenza from the second trimester to the early postpartum period. Since ...
[Editorial] Skin cancer: prevention is better t... [Published The Lancet - Aug 08 2014]
Skin cancer is now the most commonly diagnosed cancer in the USA with about 5 million people treated every year. In Germany, the Federal Statistics Bureau reported last week that treatment for skin cancer in hospital has risen more than that for any other ...
Qu Biologics to Present Crohn's Disease Compass... [Published Marketwire - Breaking News Releases - Apr 28 2014]
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 28, 2014) - Qu Biologics Inc ., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's immune system, announced that its abstract was selected for ...
Antibody Engineering & Therapeutics Call For Sp... [Published Future of BioPharma - Apr 22 2014]
The deadline for speaker abstract submissions for the Antibody Engineering & Therapeutics Event is Friday, April 25, 2014. To submit a proposal, you will be asked to select the conference topic you are interested in, provide a 100-150 word summary ...
1 2

Press Releases

sort by: Date | Relevance
Scientific guideline: Draft concept paper on gu... [Published EMA Ongoing public consultations - Aug 01 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.